Here are five quick facts:
1. On Aug. 3, TheStreet also downgraded Orthofix shares to a “hold” rating.
2. Orthofix has a 50-day moving average of $43.84 and a 200-day moving average of $43.84.
3. The company has a one-year low of $33.25.
4. The one-year high is $48.25.
5. Orthofix’s market capitalization totals $761.39 million.
More device news:
FDA’s Center for Devices and Radiological Health zones in on health IT in 2017 — 5 insights
Global orthopedic devices market to hit $41.2B by 2019: 8 highlights
Nasseo awarded NSF grant for spinal implant research: 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
